ZNF625-ZNF20 readthrough (ZNF625-ZNF20)

ZNF625-ZNF20 readthrough is a gene locus representing a naturally occurring read-through transcript between the neighboring zinc finger protein 625 (ZNF625) and zinc finger protein 20 (ZNF20) genes on chromosome 19. The transcript is a candidate for nonsense-mediated mRNA decay (NMD) and is thus unlikely to produce a functional protein product. Its function is not well understood, and no evidence supports a role as a therapeutic target or receptor. The parent genes, ZNF625 and ZNF20, are C2H2-type zinc finger proteins predicted to function as transcription factors involved in gene regulation, but the readthrough product lacks known biological or pharmacological relevance[1][2][3][4][5][7][10].\n\nThe ZNF625-ZNF20 gene is classified as a long non-coding RNA (lncRNA) or non-coding transcript, with the readthrough message being subject to degradation via nonsense-mediated decay (NMD), making it highly unlikely to result in a protein product or direct functional activity[1][3][10]. No established aliases are apparent in available databases aside from its literal designation[3]. Both ZNF625 and ZNF20 parent genes are classified as zinc finger transcription factors, which typically function in gene expression regulation, but the readthrough is not itself confirmed to function as such[2][4][5][11]. No interacting drugs, clinical biomarkers, or disease/therapeutic data are available for this readthrough. The only disease relevance mentioned relates to its genomic location potentially being altered (deleted or duplicated) in some cancers, suggesting possible regulatory or genomic instability associations but not a direct disease mechanism[2]. No safety concerns, pharmacology, or utility as a drug target are reported. Standard references (HGNC, Entrez, Ensembl, UniProtKB) confirm its annotation as a readthrough transcript, not a typical target molecule[3][10].\n\nGiven these points, \"ZNF625-ZNF20 readthrough\" is not a conventional therapeutic target, is mostly considered a non-coding RNA of unclear function, and is likely a byproduct of transcriptional readthrough with no direct protein-coding or druggable role established.

Other names

ZNF625-ZNF20 readthrough (NMD candidate)